Critical appraisal of elvitegravir in the treatment of HIV-1/AIDS
Krishan K PandeyInstitute for Molecular Virology, Saint Louis University Health Sciences Center, St Louis, MO, USAAbstract: Human immunodeficiency virus type 1 (HIV-1) integrase inhibitors belong to a novel class of antiretroviral drugs with high potency and better tolerability. Elvitegravir (EVG)...
Guardado en:
Autor principal: | Pandey KK |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c93ccd2a03dd4d348281ebbadd87a718 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Antimicrobial therapy for the treatment of opportunistic infections in HIV/AIDS patients: a critical appraisal
por: Seddon J, et al.
Publicado: (2011) -
Review of the safety, efficacy, and pharmacokinetics of elvitegravir with an emphasis on resource-limited settings
por: Lee JSF, et al.
Publicado: (2012) -
Crofelemer for the treatment of chronic diarrhea in patients living with HIV/AIDS
por: Patel TS, et al.
Publicado: (2013) -
Physiotherapy intervention as a complementary treatment for people living with HIV/AIDS
por: Pullen SD, et al.
Publicado: (2014) -
The geography of HIV/AIDS prevalence rates in Botswana
por: Kandala NB, et al.
Publicado: (2012)